Both in Pharmaceuticals
Fulcrum Therapeutics vs Arcturus Therapeutics Holdings
Over the past year FULC returned −56.9% and ARCT returned +14.5%; their daily moves had a correlation of 0.09.
FULC −56.9% ARCT +14.5%Growth of $1, one year, split-adjusted
| Metric | FULC | ARCT |
|---|---|---|
| Price | $3.71 | $11.03 |
| Market cap | $283.4M | $313.5M |
| Today | −1.59% | −9.22% |
| 1 month | +0.8% | −16.5% |
| 6 months | −49.6% | +27.8% |
| Year to date | −67.2% | +79.9% |
| 1 year | −60.4% | +16.8% |
| Revenue growth (YoY) | — | −89.5% |
| Gross margin | — | 100.0% |
| Net margin | — | −803.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 10.7× |
| Net cash | $318.8M | $191.5M |
| Dividend yield | — | — |
| Volatility (60d) | 17.2% | 114.9% |
| Short % of float | 10.6% | 19.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).